LORI HAZLEHURST

Person

RUSKIN, FL, US

People

Patents Grantslast 30 patents

Information Patent Grant
Cyclic peptide compounds and methods of use thereof
- Patent number 12,060,438
- Issue date Aug 13, 2024
- Modulation Therapeutics, Inc.
- Mark McLaughlin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cyclic peptide conjugates and methods of use
- Patent number 11,078,235
- Issue date Aug 3, 2021
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Lori Hazlehurst
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Integrin interaction inhibitors for the treatment of cancer
- Patent number 10,059,740
- Issue date Aug 28, 2018
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Lori Hazlehurst
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cyclic peptide conjugates and methods of use
- Patent number 10,011,635
- Issue date Jul 3, 2018
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Lori Hazlehurst
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Integrin interaction inhibitors for the treatment of cancer
- Patent number 8,853,149
- Issue date Oct 7, 2014
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Lori Hazlehurst
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Materials and methods for treating oncological disorders
- Patent number 8,227,434
- Issue date Jul 24, 2012
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- William S. Dalton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
HYD1 peptides as anti-cancer agents
- Patent number 7,632,814
- Issue date Dec 15, 2009
- University of South Florida
- Lori Anne Hazlehurst
- G01 - MEASURING TESTING

Patents Applicationslast 30 patents

Information Patent Application
CYCLIC PEPTIDE COMPOUNDS AND METHODS OF USE THEREOF
- Publication number 20210347826
- Publication date Nov 11, 2021
- MODULATION THERAPEUTICS, INC.
- Mark MCLAUGHLIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYCLIC PEPTIDE CONJUGATES AND METHODS OF USE
- Publication number 20190092812
- Publication date Mar 28, 2019
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Lori Hazlehurst
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INTEGRIN INTERACTION INHIBITORS FOR THE TREATMENT OF CANCER
- Publication number 20180362583
- Publication date Dec 20, 2018
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- LORI HAZLEHURST
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTEGRIN INTERACTION INHIBITORS FOR THE TREATMENT OF CANCER
- Publication number 20160257712
- Publication date Sep 8, 2016
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- LORI HAZLEHURST
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYCLIC PEPTIDE CONJUGATES AND METHODS OF USE
- Publication number 20160229892
- Publication date Aug 11, 2016
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- LORI HAZLEHURST
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PEPTIDES FOR THE TREATMENT OF CANCER
- Publication number 20150071918
- Publication date Mar 12, 2015
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Mark McLaughlin
- G01 - MEASURING TESTING
Information Patent Application
INTEGRIN INTERACTION INHIBITORS FOR THE TREATMENT OF CANCER
- Publication number 20150017259
- Publication date Jan 15, 2015
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- LORI HAZLEHURST
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PEPTIDES FOR TREATMENT OF BONE DEFICIENCY AND AUTOIMMUNE DISORDERS
- Publication number 20140322227
- Publication date Oct 30, 2014
- LORI HAZLEHURST
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HYD1 PEPTIDES FOR RELAPSED CANCER
- Publication number 20140080762
- Publication date Mar 20, 2014
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Lori Anne Hazlehurst
- G01 - MEASURING TESTING
Information Patent Application
INTEGRIN INTERACTION INHIBITORS FOR THE TREATMENT OF CANCER
- Publication number 20130065837
- Publication date Mar 14, 2013
- University of South Florida
- Lori Hazlehurst
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HYD1 Peptides as Anti-Cancer Agents
- Publication number 20080108552
- Publication date May 8, 2008
- University of South Florida
- Lori Anne Hazlehurst
- C07 - ORGANIC CHEMISTRY

LORI HAZLEHURST

Person

Patents Grantslast 30 patents

Cyclic peptide compounds and methods of use thereof

Cyclic peptide conjugates and methods of use

Integrin interaction inhibitors for the treatment of cancer

Cyclic peptide conjugates and methods of use

Integrin interaction inhibitors for the treatment of cancer

Materials and methods for treating oncological disorders

HYD1 peptides as anti-cancer agents

Patents Applicationslast 30 patents

CYCLIC PEPTIDE COMPOUNDS AND METHODS OF USE THEREOF

CYCLIC PEPTIDE CONJUGATES AND METHODS OF USE

INTEGRIN INTERACTION INHIBITORS FOR THE TREATMENT OF CANCER

INTEGRIN INTERACTION INHIBITORS FOR THE TREATMENT OF CANCER

CYCLIC PEPTIDE CONJUGATES AND METHODS OF USE

PEPTIDES FOR THE TREATMENT OF CANCER

INTEGRIN INTERACTION INHIBITORS FOR THE TREATMENT OF CANCER

PEPTIDES FOR TREATMENT OF BONE DEFICIENCY AND AUTOIMMUNE DISORDERS

HYD1 PEPTIDES FOR RELAPSED CANCER

INTEGRIN INTERACTION INHIBITORS FOR THE TREATMENT OF CANCER

HYD1 Peptides as Anti-Cancer Agents